Form 8-K - Current report:
SEC Accession No. 0001279569-24-000633
Filing Date
2024-05-17
Accepted
2024-05-17 07:19:29
Documents
15
Period of Report
2024-05-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 28923
2 PRESS RELEASE DATED MAY 17, 2024 ex991.htm EX-99.1 107343
3 GRAPHIC logo.jpg GRAPHIC 12633
  Complete submission text file 0001279569-24-000633.txt   339493

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20240517.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20240517_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20240517_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3467
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 24957692
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)